Chronic Lymphocytic Leukemia: Role of Novel Agent in the Management of CLL
0 Views
administrator
07/08/23
Moderator: Dr Rahmawati Minhadjat, Ph.D, SpPD, KHOM, FINASIM
Pembicara: Dr Dimas Bayu, SpPD, KHOM, FINASIM
SIMPOSIUM LEUKOEMIA
00:36 introduction: CLL
04:00 CLL Diagnosis
06:30 CLL Staging
10:20 CLL Cytogenetic Abnormalities
11:55 the impact of DEL 17 P
12:35 Pembahasan kasus (kasus 1)
14:25 Understanding CLL, patient Numbers and sub-groups
17:45 when to treat CLL
20:43 First line choice : Chemoimmunotherapy
22:12 First line choice : Bendamustine
22:30 Pembahasan kasus (kasus 2)
25:30 CLL -Novel Agents
28:38 Ibrutinib GOR CLL Treatment
33:30 Take Home Message
-
Category
Show more
Facebook Comments
No comments found